Alina Basnet1, Asrar Alahmadi2, Ajeet Gajra3,4. 1. Department of Medicine, SUNY Upstate Medical University, 750 E Adams Street, Syracuse, NY, 13210, USA. 2. Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. 3. Department of Medicine, SUNY Upstate Medical University, 750 E Adams Street, Syracuse, NY, 13210, USA. AjeetGajra@Gmail.com. 4. Hematology Oncology Associates of Central New York, 5008 Brittonfield Pkwy, E Syracuse, NY, 13057, USA. AjeetGajra@Gmail.com.
Abstract
PURPOSE OF REVIEW: This review aspires to summarize the landmark advancements in the management of the non-small cell lung cancer (NSCLC), both historically and contemporarily with special focus in older adults. RECENT FINDINGS: The past two decades have witnessed remarkable improvements in the diagnosis and management of lung cancer. Screening recommendations now facilitate earlier diagnosis in high-risk individuals, PET/CT scans have improved radiologic accuracy in identifying sites of disease, and surgical management with minimally invasive techniques has rendered surgery safer in those with limited physiologic reserve. Radiation enhancements, especially radiosurgery, have extended the reach and safety of radiation among high-risk populations. Finally, the revolution in precision medicine with identification of numerous actionable mutations, the advent of immunotherapy, and enhanced supportive care have revolutionized the outcomes in patients with advanced lung cancer. Older adults who represent a majority of patients battling lung cancer have not benefitted to the same extent as their younger counterparts. This special population is only expected to grow in coming days. Hence, addressing major gaps in the management of older adults with NSCLC and optimizing the care are much needed.
PURPOSE OF REVIEW: This review aspires to summarize the landmark advancements in the management of the non-small cell lung cancer (NSCLC), both historically and contemporarily with special focus in older adults. RECENT FINDINGS: The past two decades have witnessed remarkable improvements in the diagnosis and management of lung cancer. Screening recommendations now facilitate earlier diagnosis in high-risk individuals, PET/CT scans have improved radiologic accuracy in identifying sites of disease, and surgical management with minimally invasive techniques has rendered surgery safer in those with limited physiologic reserve. Radiation enhancements, especially radiosurgery, have extended the reach and safety of radiation among high-risk populations. Finally, the revolution in precision medicine with identification of numerous actionable mutations, the advent of immunotherapy, and enhanced supportive care have revolutionized the outcomes in patients with advanced lung cancer. Older adults who represent a majority of patients battling lung cancer have not benefitted to the same extent as their younger counterparts. This special population is only expected to grow in coming days. Hence, addressing major gaps in the management of older adults with NSCLC and optimizing the care are much needed.
Authors: Michael T Jaklitsch; Francine L Jacobson; John H M Austin; John K Field; James R Jett; Shaf Keshavjee; Heber MacMahon; James L Mulshine; Reginald F Munden; Ravi Salgia; Gary M Strauss; Scott J Swanson; William D Travis; David J Sugarbaker Journal: J Thorac Cardiovasc Surg Date: 2012-07 Impact factor: 5.209
Authors: Ethan B Ludmir; Walker Mainwaring; Timothy A Lin; Austin B Miller; Amit Jethanandani; Andres F Espinoza; Jacob J Mandel; Steven H Lin; Benjamin D Smith; Grace L Smith; Noam A VanderWalde; Bruce D Minsky; Albert C Koong; Thomas E Stinchcombe; Reshma Jagsi; Daniel R Gomez; Charles R Thomas; C David Fuller Journal: JAMA Oncol Date: 2019-12-01 Impact factor: 31.777
Authors: Carlos M Mery; Anastasia N Pappas; Raphael Bueno; Yolonda L Colson; Philip Linden; David J Sugarbaker; Michael T Jaklitsch Journal: Chest Date: 2005-07 Impact factor: 9.410
Authors: Daniel E Jonas; Daniel S Reuland; Shivani M Reddy; Max Nagle; Stephen D Clark; Rachel Palmieri Weber; Chineme Enyioha; Teri L Malo; Alison T Brenner; Charli Armstrong; Manny Coker-Schwimmer; Jennifer Cook Middleton; Christiane Voisin; Russell P Harris Journal: JAMA Date: 2021-03-09 Impact factor: 56.272
Authors: Herbert H Pang; Xiaofei Wang; Thomas E Stinchcombe; Melisa L Wong; Perry Cheng; Apar Kishor Ganti; Daniel J Sargent; Ying Zhang; Chen Hu; Sumithra J Mandrekar; Mary W Redman; Judith B Manola; Richard L Schilsky; Harvey J Cohen; Jeffrey D Bradley; Alex A Adjei; David Gandara; Suresh S Ramalingam; Everett E Vokes Journal: J Clin Oncol Date: 2016-09-30 Impact factor: 44.544
Authors: Harry J de Koning; Carlijn M van der Aalst; Pim A de Jong; Ernst T Scholten; Kristiaan Nackaerts; Marjolein A Heuvelmans; Jan-Willem J Lammers; Carla Weenink; Uraujh Yousaf-Khan; Nanda Horeweg; Susan van 't Westeinde; Mathias Prokop; Willem P Mali; Firdaus A A Mohamed Hoesein; Peter M A van Ooijen; Joachim G J V Aerts; Michael A den Bakker; Erik Thunnissen; Johny Verschakelen; Rozemarijn Vliegenthart; Joan E Walter; Kevin Ten Haaf; Harry J M Groen; Matthijs Oudkerk Journal: N Engl J Med Date: 2020-01-29 Impact factor: 91.245
Authors: Supriya G Mohile; William Dale; Mark R Somerfield; Mara A Schonberg; Cynthia M Boyd; Peggy S Burhenn; Beverly Canin; Harvey Jay Cohen; Holly M Holmes; Judith O Hopkins; Michelle C Janelsins; Alok A Khorana; Heidi D Klepin; Stuart M Lichtman; Karen M Mustian; William P Tew; Arti Hurria Journal: J Clin Oncol Date: 2018-05-21 Impact factor: 44.544
Authors: Cherie P Erkmen; Farouk Dako; Ryan Moore; Chandra Dass; Mark G Weiner; Larry R Kaiser; Grace X Ma Journal: Cancer Causes Control Date: 2021-01-04 Impact factor: 2.506
Authors: Peter J Mazzone; Gerard A Silvestri; Sheena Patel; Jeffrey P Kanne; Linda S Kinsinger; Renda Soylemez Wiener; Guy Soo Hoo; Frank C Detterbeck Journal: Chest Date: 2018-02-17 Impact factor: 9.410